1-2 of 2
Takayuki Fujio
Close
Sort by
Journal Articles

Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

Chikashi Yoshida, Hiroki Yamaguchi, Noriko Doki, Kazunori Murai, Masaki Iino, Yoshihiro Hatta, Makoto Onizuka, Norio Yokose, Katsumichi Fujimaki, Masao Hagihara, Gaku Oshikawa, Kayoko Murayama, Takashi Kumagai, Shinya Kimura, Hideharu Muto, Kensuke Usuki, Kenji Yokoyama, Koh Yamamoto, Nobuyuki Aotsuka, Kenichi Ishizawa, Naoki Takezako, Takuto Miyagishima, Tadao Ishida, Atsushi Shinagawa, Kentaro Wakasa, Tsuyoshi Nakamaki, Naoto Tomita, Katsutoshi Ozaki, Takayoshi Itoh, Shugo Kowata, Kenji Tajika, Takayuki Fujio, Masahiro Onozawa, Masahide Yamamoto, Takeshi Kondo, Yuho Najima, Noriyoshi Iriyama, Ikuyo Tsutsumi, Koji Oba, Hiroshi Kojima, Hisashi Sakamaki, Koiti Inokuchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 1477.
https://doi.org/10.1182/blood-2021-145483
Published: 2021
Journal Articles

Efficacy and Safety of Once-Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CBD) Regimen As Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma. -a Phase 2 Multicenter Trial-

Daisuke Kudo, MD, Takuya Komeno, MD MPH, PhD, Chikashi Yoshida, MD PhD, Ikuyo Ota Tsutsumi, MD, Kazuteru Ohashi, MD PhD, Kazuhiko Kakihana, MD PhD, Takeshi Kobayashi, MD, Noriko Doki, MD PhD, Yuho Najima, MD, Aiko Igarashi, MD, Mitsuo Hori, MD PhD, Yasushi Okoshi, MD PhD, Takayuki Fujio, MD, Atsushi Shinagawa, MD PhD, Masahide Yamamoto, MD PhD, Hina Takano, MD PhD, Takashi Kumagai, MD PhD, Koh Yamamoto, MD PhD, Shigeo Toyota, MD PhD, Yuichi Nakamura, MD PhD, Hiroshi Kojima, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2160.
https://doi.org/10.1182/blood-2018-99-113788
Published: 2018